2nd Bioequivalence Summit

5 - 6 October 2015, Boston, United States

Recent changes in the healthcare system have put a greater focus on the development and availability of generic drugs. The pharmaceutical industry has responded by exploring alternative delivery methods, creating new test designs and, most notably, developing the first American biosimilar. These advances have been met with acclaim, but they do bring new challenges. Regulatory ambiguity in testing procedures delay generic developers, and legal action from originator drug companies restricts those focusing on biosimilars. This summit will further explore the scientific necessity of this subject, while guiding experts through their collective difficulties.
Hilton Boston Back Bay

Hilton Boston Back Bay, 40 Dalton Street, Boston, 02115, United States

Organised by
ExL Pharma
Contact information
Showing all upcoming events
Start Date
End Date
Subject area
Event type

Advertisement Spotlight Advertisement

E-mail Enquiry